Optimising individualised treatment decisions for locally advanced thymoma: precision selection of minimally invasive surgery and postoperative adjuvant radiotherapy - Takeaways - MDSpire

Optimising individualised treatment decisions for locally advanced thymoma: precision selection of minimally invasive surgery and postoperative adjuvant radiotherapy

  • By

  • Xuyang Peng

  • Qi Zhang

  • Bin Huang

  • Jianyang Ding

  • Mingjiang Huang

  • Chaofan Mao

  • Xuhui Wu

  • Xi Zhu

  • June 11, 2026

  • 0 min

Share

  • 1

    Locally advanced thymoma treatment is evolving towards individualized strategies integrating minimally invasive surgery and advanced radiotherapy.

  • 2

    Minimally invasive surgical techniques can achieve oncological outcomes comparable to open surgery while reducing perioperative complications.

  • 3

    Postoperative radiotherapy decisions are guided by risk stratification models, considering WHO classification, resection margins, and tumor burden.

  • 4

    New technologies like proton therapy may reduce cardiac toxicity in postoperative radiotherapy for thymoma patients.

  • 5

    A dynamic decision-making framework is proposed to balance oncological efficacy and patient quality of life in thymoma treatment.

Original Source(s)

Optimising individualised treatment decisions for locally advanced thymoma: precision selection of minimally invasive surgery and postoperative adjuvant radiotherapy

  • by Xuyang Peng, Qi Zhang, Bin Huang, Jianyang Ding, Mingjiang Huang, Chaofan Mao, Xuhui Wu, Xi Zhu

  • June 11, 2026

Related Content

Preoperative electrolyte-based metabolic biomarkers for prognostic assessment in gastric cancer: a multicenter study

Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with inverse probability of treatment weighting retrospective study

Comparison of ultrasound-guided percutaneous radiofrequency ablation and reoperation for nerve-adjacent cervical lymph node recurrence of papillary thyroid carcinoma: a propensity score–matched study